Invention Grant
- Patent Title: CCR3 inhibition for ocular angiogenesis and macular degeneration
- Patent Title (中): CCR3抑制眼血管发生和黄斑变性
-
Application No.: US12247722Application Date: 2008-10-08
-
Publication No.: US08008092B2Publication Date: 2011-08-30
- Inventor: Jayakrishna Ambati
- Applicant: Jayakrishna Ambati
- Applicant Address: US KY Lexington
- Assignee: University of Kentucky Research Foundation
- Current Assignee: University of Kentucky Research Foundation
- Current Assignee Address: US KY Lexington
- Agency: Crowell & Moring LLP
- Main IPC: G01N33/566
- IPC: G01N33/566 ; A61K39/00
Abstract:
Provided are methods and compositions for the treatment or prevention of ocular angiogenesis and neovascularization. Administration of inhibitors of the CCR3 receptor or its ligands eotaxin (CCL11), eotaxin-2 (CCL24) or eotaxin-3 (CCL26) inhibits ocular angiogenesis.
Public/Granted literature
- US20090123375A1 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration Public/Granted day:2009-05-14
Information query
IPC分类:
